Synakis Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.9M

  • Investors
  • 11

Synakis General Information

Description

Developer of a biomaterial-based hydrogel designed to treat ocular conditions. The company's platform has developed a novel injectable, biocompatible, biodegradable, non-swelling, and transparent hydrogel that serves as a vitreous substitute for retinal surgery and can deliver engineered therapeutics, enabling patients to experience a more comfortable recovery from ocular procedures and allowing for the sustained, long-acting delivery of therapeutic agents to the eye.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 160 College Street, 510
  • Toronto, Ontario M5S 3E2
  • Canada
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 160 College Street, 510
  • Toronto, Ontario M5S 3E2
  • Canada

Synakis Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synakis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Seed Round 21-May-2026 $1.9M Completed Generating Revenue
7. Accelerator/Incubator 12-Mar-2026 Completed Generating Revenue
6. Grant 03-May-2025 Completed Generating Revenue
5. Grant 07-Mar-2024 Completed Generating Revenue
4. Accelerator/Incubator 19-May-2023 Completed Generating Revenue
3. Accelerator/Incubator 06-Jan-2023 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
To view Synakis’s complete valuation and funding history, request access »

Synakis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biomaterial-based hydrogel designed to treat ocular conditions. The company's platform has developed a no
Biotechnology
Toronto, Canada
5 As of 2026

Cambridge, MA
 

Fremont, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Synakis Competitors (2)

One of Synakis’s 2 competitors is Pykus Therapeutics, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pykus Therapeutics Venture Capital-Backed Cambridge, MA
ABVC Biopharma Corporation Fremont, CA
You’re viewing 2 of 2 competitors. Get the full list »

Synakis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synakis Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chiefswood Private Capital Corporation Minority
GlycoNet Not-For-Profit Venture Capital Minority
Ontario Centre of Innovation Not-For-Profit Venture Capital Minority
Toronto Innovation Acceleration Partners Accelerator/Incubator Minority
Ontario Genomics Accelerator/Incubator Minority
You’re viewing 5 of 11 investors. Get the full list »

Synakis FAQs

  • When was Synakis founded?

    Synakis was founded in 2019.

  • Where is Synakis headquartered?

    Synakis is headquartered in Toronto, Canada.

  • What is the size of Synakis?

    Synakis has 5 total employees.

  • What industry is Synakis in?

    Synakis’s primary industry is Biotechnology.

  • Is Synakis a private or public company?

    Synakis is a Private company.

  • What is Synakis’s current revenue?

    The current revenue for Synakis is .

  • How much funding has Synakis raised over time?

    Synakis has raised $2.05M.

  • Who are Synakis’s investors?

    Chiefswood Private Capital, GlycoNet, Ontario Centre of Innovation, Toronto Innovation Acceleration Partners, and Ontario Genomics are 5 of 11 investors who have invested in Synakis.

  • Who are Synakis’s competitors?

    Pykus Therapeutics and ABVC Biopharma are competitors of Synakis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process